Fate of most remaining Zantac lawsuits weighed by Delaware judge

GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science. Mark Cheffo, a lawyer for GSK told Judge Vivian Medinilla of the Delaware Superior Court in Wilmington that the litigation was "a case of lawyers and lawsuits getting ahead of the science – way, way ahead of the science," at the start of a three-day hearing that kicked off on Monday. No reliable studies link Zantac use to cancer, Cheffo said.